Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of immune cell signaling by SHIP1: A phosphatase, scaffold protein, and potential therapeutic target
Samantha D. Pauls, Aaron J. Marshall
European Journal of Immunology (2017) Vol. 47, Iss. 6, pp. 932-945
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis
MacRae F. Linton, Javid J. Moslehi, Vladimir R. Babaev
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2703-2703
Open Access | Times Cited: 215
Non‐IgE mediated mast cell activation
Frank A. Redegeld, Yingxin Yu, Sangeeta Kumari, et al.
Immunological Reviews (2018) Vol. 282, Iss. 1, pp. 87-113
Closed Access | Times Cited: 184
Metabolic programs of T cell tissue residency empower tumour immunity
Miguel Reina‐Campos, Maximilian Heeg, Kelly T. Kennewick, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. 179-187
Open Access | Times Cited: 62
Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein
Gerard J. Nuovo, Cynthia M. Magro, Toni Shaffer, et al.
Annals of Diagnostic Pathology (2020) Vol. 51, pp. 151682-151682
Open Access | Times Cited: 137
TIGIT signaling restores suppressor function of Th1 Tregs
Liliana E. Lucca, Pierre‐Paul Axisa, Emily Singer, et al.
JCI Insight (2019) Vol. 4, Iss. 3
Open Access | Times Cited: 111
The role of innate immunity in Alzheimer's disease
Hannah E. Ennerfelt, John R. Lukens
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 225-246
Open Access | Times Cited: 94
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
Veronika Ecker, Martina Stumpf, Lisa Brandmeier, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 58
The Wheel of p53 Helps to Drive the Immune System
Barbara Łasut-Szyszka, Marek Rusin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7645-7645
Open Access | Times Cited: 25
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 13
Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Wolfram C. M. Dempke, Peter Uciechowski, Klaus Fenchel, et al.
Oncology (2018) Vol. 95, Iss. 5, pp. 257-269
Open Access | Times Cited: 70
Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity
Xiaojie Yu, H. T. Claude Chan, Hayden Fisher, et al.
Cancer Cell (2020) Vol. 37, Iss. 6, pp. 850-866.e7
Open Access | Times Cited: 63
Immune Checkpoint Receptors Signaling in T Cells
Gianluca Baldanzi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3529-3529
Open Access | Times Cited: 35
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Gizem Terzioğlu, Tracy L. Young‐Pearse
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
Akihiro Iguchi, Sho Takatori, Shingo Kimura, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106375-106375
Open Access | Times Cited: 21
The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta‐mediated pathology
Joshua D. Samuels, Katelyn A. Moore, Hannah E. Ennerfelt, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4908-4921
Open Access | Times Cited: 21
Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease
Evelyn Tsantikos, Maverick Lau, Cassandra M.N. Castelino, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 6, pp. 2406-2418
Open Access | Times Cited: 57
Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches
Tanja Fetter, Dennis Niebel, Christine Braegelmann, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2627-2627
Open Access | Times Cited: 44
Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms
Sho Takatori, Wenbo Wang, Akihiro Iguchi, et al.
Advances in experimental medicine and biology (2019), pp. 83-116
Closed Access | Times Cited: 43
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
Kurt Sartorius, Ping An, Cheryl A. Winkler, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease
Ana Raquel Ramos, Somadri Ghosh, Christophé Erneux
Journal of Lipid Research (2018) Vol. 60, Iss. 2, pp. 276-286
Open Access | Times Cited: 41
Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
Kyohei Nakamura, Mika Casey, Harald Oey, et al.
Leukemia (2020) Vol. 34, Iss. 10, pp. 2708-2721
Closed Access | Times Cited: 36
Role of inhibitory signaling in peripheral B cell tolerance*
Andrew Getahun
Immunological Reviews (2022) Vol. 307, Iss. 1, pp. 27-42
Open Access | Times Cited: 22
Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer
Kazim Husain, Krystal Villalobos-Ayala, Valentina Laverde, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3613-3613
Open Access | Times Cited: 19
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
Vladimir Laletin, P Bernard, Cathy Costa Da Silva, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e005845-e005845
Open Access | Times Cited: 12
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1
Ather Adnan, Shree Acharya, Leila A. Alenazy, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 6, pp. 709-720
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top